Fulgent Genetics, Inc. (FLGT) Balance Sheet
FLGT balance sheet, 2025
December 31, 2025 · U.S. dollars$1.21B assets = $106.8M liabilities + $1.11B equity
Both columns are drawn to the same scale: what FLGT owns equals what it owes plus shareholders’ equity. Hover a block for its value.
FLGT financial health
Descriptive bands, not a rating. Fiscal 2025.
FLGT balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $58.0M2016 | $1.21B2025 | +40.2%/yr | |
| Total liabilities | $3.6M2016 | $106.8M2025 | +45.9%/yr | |
| Shareholders’ equity | $54.5M2016 | $1.11B2025 | +39.8%/yr | |
| Cash & short-term investments | $46.5M2016 | $336.1M2025 | +24.6%/yr | |
| Total debt | $2.7M2019 | $7.7M2025 | +19.2%/yr | |
| Net cash (debt) | $25.6M2019 | $328.4M2025 | +$302.8M | |
| Working capital | $47.3M2016 | $465.5M2025 | +$418.3M | |
| Book value per share | $3.082016 | $36.132025 | +31.5%/yr | |
| Current ratio | 14.272016 | 6.482025 | −7.79 | |
| Debt / equity | 0.032019 | 0.012025 | −0.03 | |
| Shares outstanding | 17.7M2016 | 30.8M2025 | +6.4%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
FLGT assets
FLGT liabilities and equity
FLGT debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
FLGT balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $336.1M | $258.1M | $424.2M | $526.2M | $450.5M | $299.4M | $28.3M | $37.4M | $41.4M | $46.5M |
| Cash & equivalents | $50.2M | $55.1M | $97.5M | $79.5M | $164.9M | $87.4M | $12.0M | $6.7M | $6.5M | $7.9M |
| Short-term investments | $285.9M | $203.0M | $326.7M | $446.7M | $285.6M | $211.9M | $16.3M | $30.7M | $34.9M | $38.6M |
| Receivables | $91.6M | $77.0M | $57.4M | $75.1M | $143.3M | $204.1M | $7.2M | $6.2M | $4.1M | $4.4M |
| Inventory | $10.6M | $8.4M | $5.8M | $4.3M | $12.2M | $16.5M | $277,000 | $314,000 | $231,000 | $322,000 |
| Other current assets | $112.2M | $10.1M | $20.4M | $22.2M | $6.0M | $3.7M | $1.3M | $0 | $0 | $0 |
| Total current assets | $550.5M | $353.6M | $507.8M | $627.9M | $612.0M | $523.6M | $37.1M | $43.4M | $45.4M | $50.8M |
| Property, plant & equipment (net) | $112.5M | $105.5M | $83.5M | $81.4M | $62.3M | $40.2M | $8.6M | $6.4M | $7.3M | $6.2M |
| Goodwill & intangible assets | $158.4M | $157.0M | $165.1M | $293.7M | $86.8M | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $369.3M | $570.4M | $444.0M | $339.0M | $507.0M | $132.5M | $42.8M | $7.9M | $16.8M | $25.6M |
| Other non-current assets | $22.9M | $33.5M | $34.9M | $44.1M | $10.7M | $4.1M | $251,000 | $0 | $0 | $0 |
| Total assets | $1.21B | $1.22B | $1.24B | $1.39B | $1.28B | $700.5M | $88.8M | $55.0M | $57.0M | $58.0M |
| Liabilities | ||||||||||
| Accounts payable | $18.7M | $18.4M | $15.4M | $23.1M | $20.5M | $26.5M | $1.6M | $1.3M | $2.1M | $2.8M |
| Short-term debt | $1.9M | $1.9M | $5.1M | $26.8M | $21.3M | $15.3M | $420,000 | — | — | — |
| Deferred revenue | $31.8M | $29.8M | $25.6M | $14.1M | $34.4M | $26.8M | $365,000 | — | — | — |
| Total current liabilities | $85.0M | $72.9M | $73.0M | $88.1M | $105.3M | $130.1M | $3.7M | $2.7M | $2.9M | $3.6M |
| Long-term debt | $2.0M | $2.5M | $3.0M | $3.4M | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $5.2M | $5.6M | $11.1M | $14.9M | — | $835,000 | $2.7M | — | — | — |
| Other long-term liabilities | $19.9M | $15.4M | $26.1M | $24.7M | $7.5M | $959,000 | $2.3M | $14,000 | $6,000 | $245,000 |
| Total liabilities | $106.8M | $90.8M | $102.0M | $116.2M | $112.8M | $131.1M | $6.0M | $2.7M | $2.9M | $3.6M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $2,000 | $2,000 | $2,000 | $2,000 |
| Retained earnings (deficit) | $530.0M | $590.5M | $633.2M | $801.0M | $657.6M | $150.9M | −$63.4M | −$63.0M | −$57.7M | −$55.2M |
| Treasury stock | — | — | — | — | — | — | — | — | $0 | $0 |
| Accumulated other comprehensive income | $7.5M | −$368,000 | $1.2M | −$20.9M | −$759,000 | $438,000 | $146,000 | −$35,000 | −$44,000 | −$103,000 |
| Minority interest | −$5.3M | −$4.1M | −$2.8M | $3.2M | $7.1M | — | — | — | $0 | $0 |
| Total shareholders' equity | $1.11B | $1.13B | $1.14B | $1.27B | $1.16B | $569.4M | $82.8M | $52.3M | $54.0M | $54.5M |
| Key figures | ||||||||||
| Total debt | $7.7M | $8.5M | $15.3M | $38.9M | $21.3M | $15.9M | $2.7M | — | — | — |
| Net cash (debt) | $328.4M | $249.6M | $408.9M | $487.3M | $429.2M | $283.5M | $25.6M | — | — | — |
| Working capital | $465.5M | $280.7M | $434.8M | $539.8M | $506.6M | $393.5M | $33.4M | $40.6M | $42.4M | $47.3M |
| Tangible book value | $953.6M | $976.2M | $971.0M | $973.0M | $1.07B | $569.4M | $82.8M | $52.3M | $54.0M | $54.5M |
| Book value per share | $36.13 | $37.48 | $38.14 | $40.91 | $37.41 | $23.67 | $4.42 | $2.91 | $3.05 | $3.08 |
| Shares outstanding | 30.8M | 30.2M | 29.8M | 31.0M | 31.0M | 24.1M | 18.7M | 18.0M | 17.7M | 17.7M |
| Current ratio | 6.48 | 4.85 | 6.96 | 7.13 | 5.81 | 4.02 | 9.96 | 15.80 | 15.51 | 14.27 |
| Quick ratio | 5.03 | 4.60 | 6.60 | 6.83 | 5.64 | 3.87 | 9.53 | 15.90 | 15.53 | 14.27 |
| Debt / equity | 0.01 | 0.01 | 0.01 | 0.03 | 0.02 | 0.03 | 0.03 | — | — | — |
| Equity / assets | 91.6% | 92.9% | 92.0% | 91.4% | 90.6% | 81.3% | 93.3% | 95.0% | 94.9% | 93.9% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $257.0M | $276.3M | $336.1M | $375.8M | $292.9M | $320.3M | $258.1M | $213.1M | $311.7M | $305.7M | $424.2M | $467.8M |
| Cash & equivalents | $26.3M | $23.4M | $50.2M | $117.6M | $87.9M | $67.3M | $55.1M | $58.0M | $65.1M | $54.7M | $97.5M | $84.1M |
| Short-term investments | $230.7M | $252.9M | $285.9M | $258.2M | $205.0M | $253.0M | $203.0M | $155.0M | $246.6M | $251.0M | $326.7M | $383.7M |
| Receivables | $70.5M | $75.7M | $91.6M | $78.7M | $85.0M | $80.4M | $77.0M | $64.9M | $63.7M | $59.4M | $57.4M | $54.6M |
| Inventory | $11.7M | $12.1M | $10.6M | $10.1M | $9.0M | $8.6M | $8.4M | $8.6M | $7.0M | $6.5M | $5.8M | $4.9M |
| Other current assets | $115.5M | $114.9M | $112.2M | $42.8M | $41.8M | $7.4M | $10.1M | $39.9M | $16.7M | $14.9M | $20.4M | $22.5M |
| Total current assets | $454.8M | $479.0M | $550.5M | $507.4M | $428.7M | $416.8M | $353.6M | $326.5M | $399.1M | $386.5M | $507.8M | $549.9M |
| Property, plant & equipment (net) | $113.1M | $116.3M | $112.5M | $111.9M | $110.2M | $107.1M | $105.5M | $106.8M | $93.4M | $86.7M | $83.5M | $85.3M |
| Goodwill & intangible assets | $203.1M | $207.7M | $158.4M | $160.3M | $153.1M | $155.1M | $157.0M | $159.2M | $161.0M | $163.0M | $165.1M | $286.3M |
| Long-term investments | $294.3M | $328.3M | $369.3M | $411.8M | $484.5M | $494.1M | $570.4M | $602.2M | $546.6M | $560.9M | $444.0M | $398.8M |
| Other non-current assets | $23.9M | $25.0M | $22.9M | $23.2M | $23.3M | $32.7M | $33.5M | $39.0M | $32.1M | $32.7M | $34.9M | $38.1M |
| Total assets | $1.09B | $1.16B | $1.21B | $1.21B | $1.20B | $1.21B | $1.22B | $1.23B | $1.23B | $1.23B | $1.24B | $1.36B |
| Liabilities | ||||||||||||
| Accounts payable | $15.6M | $21.1M | $18.7M | $18.1M | $18.9M | $18.2M | $18.4M | $19.8M | $19.9M | $19.6M | $15.4M | $15.8M |
| Short-term debt | $2.3M | $2.4M | $1.9M | $2.0M | $1.7M | $1.8M | $1.9M | $1.9M | $2.7M | $3.3M | $5.1M | $2.9M |
| Deferred revenue | $32.2M | $33.6M | $31.8M | $30.9M | $30.3M | $30.5M | $29.8M | $29.9M | $29.0M | $30.0M | $25.6M | $21.4M |
| Total current liabilities | $71.8M | $90.1M | $85.0M | $72.4M | $71.3M | $65.9M | $72.9M | $74.0M | $75.8M | $75.9M | $73.0M | $61.4M |
| Long-term debt | $1.5M | $1.5M | $2.0M | $2.0M | $2.0M | $2.0M | $2.5M | $2.5M | $2.5M | $2.5M | $3.0M | $0 |
| Lease obligations | $7.5M | $7.9M | $5.2M | $5.1M | $5.0M | $5.2M | $5.6M | $6.1M | $9.4M | $9.5M | $11.1M | — |
| Other long-term liabilities | $20.0M | $20.6M | $19.9M | $19.4M | $14.9M | $15.1M | $15.4M | $22.4M | $25.1M | $24.8M | $26.1M | $35.1M |
| Total liabilities | $93.2M | $112.2M | $106.8M | $93.8M | $88.2M | $83.0M | $90.8M | $98.9M | $103.4M | $103.2M | $102.0M | $96.6M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $4,000 | $4,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 |
| Retained earnings (deficit) | $475.6M | $505.1M | $530.0M | $553.4M | $560.0M | $578.9M | $590.5M | $596.4M | $611.0M | $619.7M | $633.2M | $761.3M |
| Accumulated other comprehensive income | $1.9M | $4.5M | $7.5M | $6.8M | $6.0M | $4.3M | −$368,000 | $9.2M | −$877,000 | −$1.1M | $1.2M | −$16.9M |
| Minority interest | −$5.6M | −$5.7M | −$5.3M | −$5.1M | −$4.9M | — | — | — | — | — | — | — |
| Total shareholders' equity | $1.00B | $1.05B | $1.11B | $1.13B | $1.12B | $1.13B | $1.13B | $1.14B | $1.13B | $1.13B | $1.14B | $1.26B |
| Key figures | ||||||||||||
| Total debt | $9.4M | $9.9M | $7.7M | $7.5M | $7.4M | $7.7M | $8.5M | $9.0M | $12.3M | $12.4M | $15.3M | $2.9M |
| Net cash (debt) | $247.6M | $266.4M | $328.4M | $368.3M | $285.5M | $312.7M | $249.6M | $204.0M | $299.4M | $293.3M | $408.9M | $464.9M |
| Working capital | $383.0M | $388.9M | $465.5M | $434.9M | $357.4M | $350.9M | $280.7M | $252.5M | $323.4M | $310.6M | $434.8M | $488.4M |
| Tangible book value | $798.5M | $842.1M | $953.6M | $965.6M | $963.5M | $972.1M | $976.2M | $979.3M | $971.5M | $966.9M | $971.0M | $972.4M |
| Book value per share | $35.77 | $34.00 | $36.13 | $36.62 | $36.21 | $36.56 | $36.97 | $37.43 | $37.63 | $37.96 | $38.16 | $41.94 |
| Shares outstanding | 28.0M | 30.9M | 30.8M | 30.7M | 30.8M | 30.8M | 30.7M | 30.4M | 30.1M | 29.8M | 29.8M | 30.0M |
| Current ratio | 6.34 | 5.31 | 6.48 | 7.01 | 6.01 | 6.32 | 4.85 | 4.41 | 5.27 | 5.09 | 6.96 | 8.95 |
| Quick ratio | 4.56 | 3.91 | 5.03 | 6.28 | 5.30 | 6.08 | 4.60 | 3.76 | 4.96 | 4.81 | 6.60 | 8.51 |
| Debt / equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| Equity / assets | 92.0% | 90.8% | 91.6% | 92.7% | 93.1% | 93.5% | 92.9% | 92.3% | 91.9% | 91.9% | 92.0% | 92.7% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 27, 2026); data from EODHD.
FLGT financial position
At the end of fiscal 2025 (December 31, 2025), Fulgent Genetics had total assets of $1.2 billion (down 0.5% from a year earlier), total liabilities of $106.8 million and shareholders' equity of $1.1 billion. It held $336.1 million in cash and short-term investments against $7.7 million of debt, a net cash position of $328.4 million. Its current ratio was 6.48. In the latest quarter (ended June 30, 2026) total assets were $1.1 billion and equity $1.0 billion.
Related: FLGT income statement, FLGT cash flow statement, FLGT key metrics. See the FLGT stock overview for the latest quote and news.
FLGT balance sheet FAQ
What are Fulgent Genetics's total assets?
Fulgent Genetics reported total assets of $1.2 billion at the end of fiscal 2025 (December 31, 2025), compared with $1.2 billion a year earlier.
How much debt does Fulgent Genetics have?
Fulgent Genetics had $7.7 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.01.
How much cash does Fulgent Genetics have?
Fulgent Genetics held $336.1 million in cash and short-term investments at the end of fiscal 2025; with $7.7 million of debt that is net cash of $328.4 million.
What is Fulgent Genetics's book value?
Fulgent Genetics's shareholders' equity (book value) was $1.1 billion at the end of fiscal 2025, or $36.13 per share.
What is Fulgent Genetics's current ratio?
Fulgent Genetics had current assets of $550.5 million and current liabilities of $85.0 million, a current ratio of 6.48 (it can cover its short-term obligations).
How much goodwill does Fulgent Genetics have?
Fulgent Genetics carried $158.4 million of goodwill and intangible assets, 13.0% of total assets, at the end of fiscal 2025.